Table 2.

Practitioner Variables Associated With Increased Likelihood of Testing for HBV Before Chemotherapy

Predictor Variable	OR	95% CI
Predominantly hematologic v solid tumor practice	8.2	4.1 to 16.5
Previous experience with HBV reactivation	3.8	1.9 to 7.6
Able to correctly identify risk of HBV reactivation after treatment of solid tumor or hematologic malignancy	3.3	1.6 to 6.9
Years in practice (≤ 10 v > 10)	2.2	1.1 to 4.3
Female sex	2.1	1.0 to 4.1

Abbreviations: HBV, hepatitis B virus; OR, odds ratio.